Combined first trimester screen or noninvasive prenatal testing or both.

about

Noninvasive prenatal testing in routine clinical practice for a high-risk population: Experience from a center.

P2860

Q37354838-09853959-C971-4A1E-9855-1F2805E6FEA3

P2860

Combined first trimester screen or noninvasive prenatal testing or both.

Item

http://www.wikidata.org/entity/Q43143925

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Combined first trimester screen or noninvasive prenatal testing or both.

@en

Combined first trimester screen or noninvasive prenatal testing or both.

@nl

type

Item

label

Combined first trimester screen or noninvasive prenatal testing or both.

@en

Combined first trimester screen or noninvasive prenatal testing or both.

@nl

prefLabel

Combined first trimester screen or noninvasive prenatal testing or both.

@en

Combined first trimester screen or noninvasive prenatal testing or both.

@nl

P1476

Combined first trimester screen or noninvasive prenatal testing or both.

@en

P2093

Tony Yew Teck Tan

http://www.w3.org/2001/XMLSchema#string

P2860

DNA Sequencing versus Standard Prenatal Aneuploidy Screening

Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center

Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.

Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.

The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort

Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy.

Screening for fetal aneuploidies at 11 to 13 weeks.

Chronotherapy with low-dose aspirin for prevention of complications in pregnancy.

P304

1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.11622/SMEDJ.2015001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25640091

http://www.w3.org/2001/XMLSchema#string

P932

4325569

http://www.w3.org/2001/XMLSchema#string

Combined first trimester screen or noninvasive prenatal testing or both.

about

P2860

P2860

Combined first trimester screen or noninvasive prenatal testing or both.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932